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Abstract Depressive symptoms are commonly reported
by individuals suffering from a chronic medical condition.
Mindfulness-based cognitive therapy (MBCT) has been
shown to be an effective psychological intervention for
reducing depressive symptoms in a range of populations.
MBCT is traditionally given in a group format. The aim
of the current pilot RCT was to examine the effects of
group-based MBCT and individually based MBCT for
reducing depressive symptoms in adults suffering from
one or more somatic diseases. In this study, 56 people
with a somatic condition and comorbid depressive symp-
toms (i.e., Beck Depression Inventory-II [BDI-II] ≥14)
were randomized to group MBCT (n = 28) or individual
MBCT (n = 28). Patients filled out questionnaires at three
points in time (i.e., pre-intervention, post-intervention,
3 months follow-up). Primary outcome measure was se-
verity of depressive symptoms. Anxiety and positive well-
being as well as mindfulness and self-compassion were
also assessed. We found significant improvements in all
outcomes in those receiving group or individual MBCT,
with no significant differences between the two conditions
regarding these improvements. Although preliminary (given
the pilot nature and lack of control group), results suggest that
both group MBCT and individual MBCT are associated with
improvements in psychological well-being and enhanced
skills of mindfulness and self-compassion in individuals with
a chronic somatic condition and comorbid depressive symp-
toms. Our findings merit future non-inferiority trials in larger
samples to be able to draw more firm conclusions about the
effectiveness of both formats of MBCT.
Keywords Mindfulness-based cognitive therapy .
Individual . Depression . Somatic illness . RCT
Introduction
The presence of a chronic somatic disease plays a
prominent role in the development of depression, with
about 9−23 % of people with one or more chronic somatic
diseases having comorbid depression (Moussavi et al.
2007). Given this high prevalence, the burden of depres-
sion, and its negative consequences for self-care and med-
ical treatment adherence, it is crucial to develop and test
treatments that are acceptable and effective in reducing de-
pressive symptoms. In terms of treatment preferences, the
majority of persons experiencing depressive symptoms pre-
fer psychological rather than antidepressant medication
(Dwight-Johnson et al. 2000).
Mindfulness-based cognitive therapy (MBCT) is one of the
available psychological interventions that focus on reducing
depressive symptoms (Segal et al. 2002). Mindfulness refers
to being aware of the present moment, by intentionally paying
attention without judgment (Kabat-Zinn 2003). MBCT is
based on mindfulness-based stress reduction (MBSR), devel-
oped by Kabat-Zinn (1979), a group program helping people
to cope with severe medical conditions and their psychologi-
cal impact. MBCT combines mindfulness exercises such as
meditation with cognitive behavioral exercises and psycho-
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education about depression. MBCT is a structured 8-week
group program, with weekly 2- to 2.5-h sessions. Doing daily
homework exercises is a central part of MBCT. MBCT was
specifically developed to teach formerly depressed people to
prevent relapse (Teasdale et al. 2000), but is currently also
employed for treating current depressive symptoms. Meta-
analyses concluded that mindfulness-based interventions are
effective for relapse prevention (Piet and Hougaard 2011;
Fjorback et al. 2011) as well as reducing current depressive
symptoms in both healthy populations (Chiesa and Serretti
2009), clinical populations (Hofmann et al. 2010), and somat-
ic populations (Piet et al. 2012), with effect sizes being com-
parable to those of alternative type of treatments, including
cognitive behavioral therapy (CBT) (Beltman et al. 2010).
Mindfulness-based interventions are usually given in
groups of 8 to 12 participants, and most research on the effi-
cacy of mindfulness-based interventions is based on these
group interventions. So far, very few studies have examined
whether this group format of MBCT is more effective than
alternative formats, particularly an individual delivery. Both
clearly have advantages and disadvantages. The group deliv-
ery of MBCT may provide participants observational learn-
ing, encouragement, emotional support, a sense of common
humanity and a wider perspective on problems, and possibly
an increased motivation to do daily homework exercises. In
addition, group sessions cost much less than individual ses-
sions. Yet, this group format may not be the right format for
everyone. Very little is known about this. One study in em-
ployees from large healthcare organizations on preferences for
MBCTsuggests that a subgroup of people preferred individual
MBCT rather than group MBCT (Lau et al. 2012). Another
recent study also suggest that people may prefer individual
over group format (Wahbeh et al. 2014b). A qualitative study
in cardiac patients participating in an MBCT course reported
that although many patients found the group experience to be
normalizing and supporting (Griffiths et al. 2009), some pa-
tients found the group sharing frustrating and disappointing.
An individual format may particularly be beneficial for
people who otherwise do not want to participate in a
mindfulness-based intervention or are not able to do so, due
to severe illness, disabilities or disabling symptoms like pain
or fatigue, or constrained time schedules. When offering
MBCT individually, the trainer can adapt the setting and
timing to the specific needs of the patient and give full atten-
tion to the person. Another advantage could be that partici-
pants are not overwhelmed by the stories and difficulties of
others. Yet, disadvantages are the lack of encouragement, a
sense of common humanity, and motivation to do daily home-
work exercises by other participants. On the other hand, this
format may be more feasible, as it might also not always be
possible to participate or offer a group program. This may
explain why trainers in clinical practice have started to offer
MBCT in an individual format, even while there is currently a
lack of empirical evidence for the efficacy of this format. In
addition, this individual format is likely to be much more
costly compared to the group delivery of the mindfulness-
based program. One uncontrolled, small pilot study in persons
with elevated stress, examining a 6-weekly 90-min individual
MBCT program, found promising results, with significant de-
creases in negative affect and increases in mindfulness
(Wahbeh et al. 2014a).
Given the lack of empirical evidence for the efficacy of an
individual format of MBCT, more research is needed about the
possible benefits of this type of MBCT. Recently, a structured
individual MBCT protocol was developed, adapting the stan-
dardized groupMBCT into an 8-week individual program, here-
by following the structure and content of each session and the
type of homework as much as possible (Schroevers et al. 2015).
In a pilot RCTstudy in depressed patients with diabetes, individ-
ual MBCT was found to be effective in reducing depressive
symptoms, compared to a waitlist control condition
(Schroevers et al. 2015). In a larger trial, also in depressed pa-
tients with diabetes, the efficacy of individually administered
MBCT and individually administered CBT was examined in
comparison to a waiting list control condition, showing that both
interventions were equally effective in reducing depressive
symptoms (Tovote et al. 2014).
The aim of the present pilot RCT study was to examine the
effects of individual MBCT and group MBCT on depressive
symptoms in depressed people with one or more chronic so-
matic diseases. We also examined effects on secondary out-
comes, including anxiety, positive well-being, mindfulness,
and self-compassion. Although set up as a pilot and not as a
non-inferiority trial, we also explored differences between
group MBCT and individual MBCT in their effects. Patients
filled out questionnaires at three points in time (i.e., pre-inter-
vention, post-intervention, 3 months follow-up). We expected




Eligible participants were patients with a chronic somatic dis-
ease, as diagnosed by their general practitioner (GP), aged ≥18
and ≤70 years, with depressive symptoms in the past 2 weeks
as indicated by a Beck Depression Inventory-II (BDI-II) score
≥14 (cutoff score indicating the presence of at least mild
symptoms of depression). Exclusion criteria were as follows:
not being able to read and write Dutch, the presence of severe
psychiatric comorbidity or cognitive impairment, acute suicid-
al ideations or behavior, receiving an alternative psychological
treatment during or less than 2months prior to study inclusion,
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and new or unstable treatment with an antidepressant in the
last 2 months prior to study inclusion.
Procedure
This study was a pilot randomized controlled trial with two
active treatment conditions, namely, group MBCT and indi-
vidual MBCT. The research protocol was reviewed and ac-
cepted by the Medical Ethical Committee of the University
Medical Center Groningen (UMCG), the Netherlands. The
study was conducted in accordance with the principles of the
Declaration of Helsinki (version 2008) and the Medical
Research Involving Human Subjects Act (WMO).
Patients were recruited from October to December 2013.
We used a convenience sample, recruited by advertisements in
local newspapers. In the advertisement, people were informed
that the aim of the study was to examine the effects of a
mindfulness-based intervention on mood and that the study
would use randomization to allocate people to one of two
formats. Those interested in study participation were asked
to fill in a screening questionnaire (i.e., BDI-II, see measures)
(Fig. 1). When reporting elevated levels of depressive symp-
toms, patients were called for a telephone interview to check
all eligibility criteria. Eligible patients providing written in-
formed consent were randomized into group or individual
MBCT. Computerized randomization was carried out strati-
fied by gender, baseline BDI-II, and use of antidepressant
medication. Allocation was concealed, as the researcher ad-
mitting persons to the study was not aware of the upcoming
assignment by the computerized randomization program. Two
thirds of the randomized participants received MBCT (group
or individual) in October–December; the other third received
the training in January and February in 2014.
Both group and individual MBCTs are structured interven-
tions aimed at reducing depressive symptoms, and the MBCT
trainers used a detailed session-by-session protocol. The
group MBCT intervention was based on the standardized
and well-described 8-week MBCT group protocol (Segal
et al. 2002). The individual MBCT intervention was an
adapted version of the standardized 8-week MBCT group
protocol. We have written an extensive treatment manual, in-
cluding a detailed session-by-session description, transcripts
of all exercises, and descriptions of how to perform the enqui-
ry (for details, see Tovote et al. 2014). In short, the 8-weekly
group sessions of 120–150 min were adapted to 8-weekly
individual sessions of 60 min; as a consequence, we shortened
the duration of the exercises within the sessions and took out
the cognitive exercise during the second session. For both
group and individual MBCTs, participants received an infor-
mational booklet and CDs with guided exercises during the
first session. CDs were based on the Dutch version of the
guided exercises that accompanied Segal et al. (2002), lasting
30 min each. Participants in both conditions were asked
to practice at home every day for at least 30 min.
Homework assignments consisted of the guided mind-
fulness exercises on the CD together with informal ex-
ercises such as mindful eating. Both interventions were
delivered by trained therapists who received a 3-day
training by an experienced, qualified mindfulness trainer
and supervision every 3 weeks throughout the interven-
tion period.
Measures
Patients filled out self-report questionnaires at their homes
(i.e., without the trainer or researcher being present) at three
points in time (i.e., pre-intervention, post-intervention,
3 months follow-up), including scales to assess depressive
symptoms, anxiety, positive well-being, mindfulness, and
self-compassion (see below).
Data on demographic characteristics (i.e., age, gender,
education, employment, and marital status) and the presence
of chronic somatic diseases were collected at pre-interven-
tion. At post-intervention, we asked people about their pref-
erence for individual or group MBCT at the start of the
study (on a five-point scale, ranging from a strong prefer-
ence for group MBCT to a strong preference for individual
MBCT) and their satisfaction with the actually received for-
mat of MBCT (on a five-point scale, ranging from very
satisfied to very dissatisfied).
The primary outcome measure, severity of depressive
symptoms, was assessed with the BDI-II (Beck et al.
1996). The BDI-II is a 21-item self-report questionnaire,
measuring symptoms of depression such as sadness, loss
of interest, and hopelessness during the last 2 weeks.
The presence of each symptom is rated on a four-
point scale ranging from 0 (Bnot at all^) to 3 (Bmost
of the time^). A score from 14 to 19 indicates mild
depression, a score from 20 to 28 indicates moderate
depression, and a score ≥29 indicates severe depression.
The reliability of the BDI-II as indicated by Cronbach’s
alpha was adequate in the current study (α = 0.77–0.95,
for the different time points).
Anxiety was assessed by the Generalized Anxiety
Disorder 7 (GAD-7), a seven-item self-report instrument
(Spitzer et al. 2006). Respondents are asked to report the
frequency with which they experience worrying, feeling
restless, annoyed, or afraid during the past 2 weeks.
Each item is scored 0 (Bnot at all^) to 3 (Bnearly every
day^). A total sum score of 5 to 10 indicates mild anx-
iety, a score of 11 to 15 indicates moderate anxiety, and
a score of >15 indicates severe anxiety. The reliability in
this study was good (α = 0.79–0.90, for the different
time points).
Positive well-being was assessed with the Well-Being
Index (WHO-5) (Bech et al. 2003). This self-report instrument
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consists of five items that are scored on a six-point
scale from 0 (Bnot present^) to 5 (Bconstantly present^).
The items are about positive mood, vitality, and general
interest in relation to the last 2 weeks. The total sum
score is converted to a score between 0 and 100, with a
score ≤50 indicating poor well-being. In this study, the
scale’s reliability was good (α = 0.83–0.92, for the dif-
ferent time points).
Mindfulness was assessed with the Five Facet
Mindfulness Questionnaire (FFMQ), which is one of
the most widely used mindfulness questionnaires (Baer
et al. 2006). This 39-item scale assesses five compo-
nents of mindfulness: observing, describing, non-
judging of experience, acting with awareness, and non-
reactivity to inner experience. Participants rated the de-
gree to which every statement is true on a five-point
Likert scale ranging from 1 (Bnever or very rarely true^)
to 5 (Bvery often or always true^). A total score was
calculated with higher scores indicating greater levels of
mindfulness. In this study, the reliability was good (α =
0.85–0.94, for the different time points).
Self-compassion was assessed with the Self-Compassion
Scale—Short Form (Raes et al. 2011), which has a nearly
perfect correlation with the long scale when examining total
scores (Neff 2003). The scale consists of 12 items that can
be answered on a five-point Likert scale, ranging from 1,
Bseldom or never,^ to 5, B(almost) always^. It measures
components of self-compassion like self-kindness, common
humanity, self-judgement, isolation, over-identification, and
mindfulness. The short form demonstrated adequate reli-
ability (Raes et al. 2011). Also in this study, the reliability
was good (α = 0.85–0.89, for the different time points).
Data Analyses
SPSS Statistics 22 was used for all analyses. Data were ana-
lyzed by the second author (not blinded). To investigate if
there were differences at baseline between the groups
Fig. 1 Flowchart of study
inclusion
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regarding demographic and clinical variables as well as pri-
mary and secondary outcome measures, t tests, chi-squared
tests, and Fisher’s exact tests were used. Intention-to-treat
methods were used for all analyses. We performed sensitivity
analyses based on participants with no missing data and
datasets with different imputation methods (e.g., last observa-
tion carried forward, regression imputation, group mean sub-
stitution). As all analyses revealed a similar pattern of results,
we imputed missing data based on the group mean score and
used these scores in the intention-to-treat analyses. In addition
to intention to treat, we performed similar analyses on com-
pleted data, without imputations. Repeated measures analyses
were performed to examine the effects within both interven-
tion conditions. We also tested whether the time × condition
(i.e., group versus individual MBCT) was significant, in order
to examine differences between the two conditions with re-
spect to treatment effects. Effect sizes were calculated using
Cohen’s d (Cohen 1992).
Results
This study was set up as a pilot study, not as an equivalence trial.
Given the resources and time schedule of the project, we had a
limited time period to recruit participants for the study. In total,
284 people were screened with the BDI-II, of which 56 people
provided informed consent and were randomized to either indi-
vidualMBCT (N = 28) or groupMBCT (N = 28) (see Fig. 1). As
can be seen in Table 1, participating patients were mostly female,
on average 52 years old, having a relationship, and highly edu-
cated, with no significant differences between group and individ-
ual MBCT participants. Two thirds of patients reported having
one chronic disease; the other third reported two or more dis-
eases. In total, 77 illnesses were reported by patients, with most
common being chronic pain (19 times reported), disorders of
joints (16 reported), cardiac disease (8 reported), and diabetes
(7 reported). When asked at post-intervention, about two thirds
of people said that they had preferred individual MBCT at the
start of the study (i.e., before randomization). After having re-
ceived MBCT, people in both conditions were equally satisfied
with the actually received format of MBCT.
Table 2 shows the means and standard deviations on all
study variables for both group and individual MBCTs at the
three points in time (i.e., imputedmissing data). There were no
significant pre-intervention differences between the two con-
ditions on any of these variables (p > 0.05). Effect sizes refer
to Cohen’s d, with values ranging from 0.2 to 0.5 indicating
small effects, values from 0.5 to 0.8 indicating moderate ef-
fects, and values >0.8 indicating large effects of interventions.
Using intention-to-treat analyses, we found significant im-
provements in all outcomes within group MBCT and within
individual MBCT (p < 0.001), with effect sizes indicating
mostly large effects (>0.8) within both conditions. These
results indicate that patients in both conditions reported sig-
nificant reductions in depressive symptoms and anxiety, and
increases in well-being, mindfulness, and self-compassion
over time. Most change was seen between T1 and T2 and thus
between pre- to post-intervention, with improvements main-
tained till T3, i.e., at 3 months follow-up. We did not find
significant two-way time x condition interactions (p > 0.20).
This indicates that we did not find significant differences be-
tween group MBCT and individual MBCT in the improve-
ments in all of our primary and secondary outcomes. In addi-
tion, we performed similar analyses, this time using completed
data, without imputation. Again, all outcomes showed signif-
icant improvements within the two variants ofMBCT fromT1
to T3 (p < 0.001). No interaction effects were found for time x
condition (p > 0.10).
Discussion
This is the first RCT that investigated the efficacy of group
MBCT and individually delivered MBCT. The study was con-
ducted in patients with one or more chronic somatic condition(s)
with comorbid depressive symptoms. It should be noted that it
was set up as a pilot study, rather than a non-inferiority trial. As
hypothesized, both group and individual MBCTs were associat-
ed with significant improvements in depressive symptoms, with
no significant difference in improvement between the two con-
ditions. The decrease in depressive symptoms can be regarded as
a clinically relevant improvement, as the mean post-intervention
levels of depressive symptoms were below the cutoff of the scale
(i.e., BDI-II) that we used. Patients in both conditions also report-
ed significant reductions in anxiety and increases in positive
well-being, mindfulness, and self-compassion. Again, no signif-
icant differences were found between the two conditions with
respect to these improvements. We also observed that, post-in-
tervention, most patients were satisfiedwith the format ofMBCT
they received. This is important information, as two thirds of
people reported that they had preferred individual MBCT at the
start of the study.
The positive effects of group MBCTon symptoms of anxiety
and depression as well as well-being are in line with the large
amount of studies demonstrating the benefits of this group inter-
vention for psychological functioning (Hofmann et al. 2010;
Fjorback et al. 2011; Piet et al. 2012). Importantly, we found
similar effects in patients receiving individual MBCT. This adds
to the evidence from previous RCTs that individual MBCT is
effective in reducing symptoms of depression and anxiety and in
improving well-being in depressed patients with diabetes
(Schroevers et al. 2015; Tovote et al. 2014). Findings are also
consistent with results from a recent uncontrolled pilot study on
individual mindfulness-based training showing significant de-
creases in perceived stress and negative affect over time
(Wahbeh et al. 2014a).
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Our results seem in contrast to findings regarding CBT, with a
meta-analysis suggesting that individual CBT is more effective
than group CBT for treating depressive symptoms in patients
with a somatic disease (Beltman et al. 2010). A meta-analysis
on group versus individual therapies for depression found that
generally individual therapy was only somewhat more effective
than group therapies and this advantage of individual therapies
was not significant at follow-up any more (Cuipers et al. 2008).
Our results suggest that, with respect to MBCT, both group and
individual formats are about equally effective, yet given that our
pilot studywas not set up as an equivalence trial and is the first to
examine this, larger studies are needed to draw more firm
conclusions.
It is important to note that both group and individual MBCTs
also led to improvements in mindfulness and self-compassion.
Similar findings have been reported in previous studies on group
MBCT (Kuyken et al. 2010; Nyklicek and Kuijpers 2008). The
fact that increases in these skills were also found in the partici-
pants receiving individual MBCT suggests that the traditional
format for mindfulness-based training in a supportive group en-
vironment is not a requirement for cultivating skills to bemindful
and self-compassionate.A possible explanationmay be that these
increases inmindfulness and self-compassion are due to the daily
mindfulness exercises that patients do (Snippe et al. 2015a).
Several limitations need to be acknowledged while
interpreting the findings. First, as the study was set up as a
pilot study, the power (i.e., based on the actual number of
patients in the analyses) to detect effects was somewhat re-
duced. We also did not have a fully powered sample to test
equivalence, as this would have required 115 participants in
Table 1 Characteristics of the study participants
Group MBCT Individual MBCT Total (n = 56) Differences between
(n = 28) (n = 28) Group and individual MBCT
Age (years) M (SD) 52.1 (9.9) 52.4 (11.7) 52.2 (10.7) t = 0.1
p = 0.92
Gender n (%)
Male 7 (25 %) 6 (21 %) 13 (23 %) χ2 = 0.10
Female 21 (75 %) 22 (79 %) 43 (77 %) p = 0.75
Relationship status n (%)
In a relationship 24 (86 %) 19 (68 %) 43 (77 %) χ2 = 2.50
Not in a relationship 4 (14 %) 9 (32 %) 13 (23 %) p = 0.11
Education n (%)
Lower level vocational school 3 (11 %) 1 (3 %) 4 (7 %) p = 0.35d
Secondary education/advanced 13 (46 %) 10 (36 %) 23 (41 %)
Level vocational school
Higher or University education 12 (43 %) 17 (61 %) 29 (52 %)
Employment n (%)
Employed 9 (32 %) 12 (43 %) 21 (38 %) χ2 = 0.69
Not employed 19 (68 %) 16 (57 %) 35 (62 %) p = 0.41
Somatic disease n (%)
One disease 17 (61 %) 20 (71 %) 37 (66 %) χ2 = 0.72
More than one disease 11 (39 %) 8 (29 %) 19 (34 %) p = 0.40
Preference formata n (%)b
No preference 6 (21 %) 7 (26 %) 13 (24 %) p = 0.99d
Group 5 (18 %) 4 (15 %) 9 (16 %)
Individual 17 (61 %) 16 (59 %) 33 (60 %)
Satisfaction received formatc (%)a
Satisfied 23 (86 %) 25 (92 %) 48 (90 %) p = 0.70d
Neutral 2 (7 %) 1 (4 %) 3 (5 %)
Dissatisfied 2 (7 %) 1 (4 %) 3 (5 %)
a Patients’ preference for individual or group MBCT at the start of the study was assessed at post-intervention
bData is missing for one person
c Satisfaction with the actual received format (i.e., individual or group) was assessed at post-intervention
d Fisher’s exact test
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each condition. However, given the relatively small difference
in depressive symptoms between the two conditions at T2 and
T3, results suggest no meaningful difference in outcomes be-
tween the two formats of MBCT. A second limitation is that
we had no control group. Therefore, we cannot be certain that
the effects are due to MBCT or to a time effect. However,
when comparing the reductions in depressive symptoms in
this study with a previous study on individual MBCT which
did include a control group, it seems likely that the improve-
ments in the current study were strongly due to the interven-
tions. Third, participants were recruited using convenience
sampling, which has been associated with selection bias, here-
by reducing generalizability of the results. Fourth, we had
limited information on patients’ clinical characteristics, with
the sample being heterogeneous with respect to the number
and type of comorbidity. This limits the generalization of the
results to other groups. Fifth, it should be noted that patients’
preference for the format of MBCT (group or individual) was
asked retrospectively at the post-intervention assessment, so
after having received MBCT. However, it is interesting to see
that even while the majority of patients in both formats are
then satisfied with the received format, about two thirds did
report that, at the start, they preferred individual over group
format. Finally, all outcomes were measured by self-report
and we had no objectively assessed information available
(e.g., clinical interview for assessing depressive symptoms).
To conclude, group MBCT and individual MBCT both
seem effective in reducing depressive symptoms in patients
with a chronic somatic disease. Given the current use of indi-
vidual MBCT in clinical practice, without previous empirical
evidence to support this, our results are innovative and of
clinical importance. In the study, we also observed that partic-
ipants were generally satisfied with the format of MBCT they
received, while beforehand about two thirds had preferred
individual MBCT. Previous research has found that patients’
expectations of outcomes of MBCT are predictive of home-
work compliance, treatment completion, and the amount of
improvement in depressive symptoms over the course of
MBCT (Snippe et al. 2015b). Given this importance of pa-
tients’ expectations, it may be valuable to offer patients the
format of MBCT (i.e., group or individual) of which they
expect the most positive outcomes, especially given our pre-
liminary evidence that both are equally effective.
Future research, particularly a non-inferiority trial, is needed
to confirm our results and to test more firmly whether both group
and individual MBCTs are equally effective. Future research is
also needed to examine factors that can indicate whether certain
subgroups of patients are more likely to benefit from group or
individual MBCT or to prefer individual over group MBCT or
vice versa. Research in the field of CBT suggests that the under-
lying mechanisms may also differ between group and individual
approaches, with different factors mediating improvements in
outcomes (Hedman et al. 2013). More research is needed to
examine whether distinct mediating factors explain the effects
of group and individualMCBT. Thismay provide a better insight
into the working mechanism of both formats and provide direc-
tions on how to optimize their efficacy.
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Table 2 Means and standard deviations for all study variables in group MBCT and individual MBCT







Depression I-MBCT 25.0 (8.8) 13.1 (10.1) 12.9 (11.0) 11.6 (8.2, 15.5) 12.1 (8.8, 15.4) 41.1* 1.25 1.21
G-MBCT 24.0 (6.0) 10.8 (5.9) 11.2 (10.0) 13.3 (10.2, 16.4) 12.9 (9.1, 16.6) 37.7* 2.23 1,57
Anxiety I-MBCT 9.8 (4.3) 6.7 (4.9) 6.7 (4.4) 3.0 (1.7, 4.4) 3.0 (1.7, 4.4) 14.6* 0.66 0.70
G-MBCT 9.8 (3.7) 5.0 (3.1) 5.6 (4.7) 4.8 (3.3, 6.3) 4.2 (2.1, 6.3) 17.0* 1.40 1.00
Well-being I-MBCT 28.1 (16.6) 46.1 (20.1) 49.9 (17.7) −17.9 (−24.9, −11.0) −21.8 (−29.0, −14.5) 23.1* 0.97 1.27
G-MBCT 28.9 (15.3) 50.9 (20.9) 53.7 (22.9) −21.9 (−30.4, −13.5) −24.8 (−33.4, −16.1) 21.7* 1.20 1.27
Mindfulness I-MBCT 112.5 (14.5) 129.4 (16.4) 131.0 (18.3) −16.9 (−23.2, −10.7) −18.5 (−25.8, −11.2) 23.8* 1.09 1.12
G-MBCT 114.4 (16.5) 131.2 (14.6) 129.9 (18.1) −16.8 (−22.1, −11.6) −15.5 (−20.5, −10.4) 27.3* 1.08 0.90
Self-compassion I-MBCT 2.5 (0.5) 3.0 (0.6) 3.1 (0.6) −0.5 (−0.7, −0.2) −0.6 (−0.8, −0.3) 13.7* 0.85 1.07
G-MBCT 2.7 (0.6) 3.2 (0.6) 3.3 (0.6) −0.5 (−0.7, −0.3) −0.6 (−0.8, −0.5) 26.0* 0.78 0.97
dT1/T2 effect sizes based on within-group changes between T1 and T2, dT1/T3 effect sizes based on within-group changes between T1 and T3. I-MBCT
individual MBCT, G-MBCT group MBCT
*p < 0.001 based on within-group changes between T1 and T3
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